CSR Biotech key facts
- Developer and manufacturer of super-resolution imaging instruments for living cells.
- It has raised $14.1M; the latest was Later Stage VC in Mar 2026.
- Notable investors include CAS Star, Qiming Venture Partners, Fortune Capital, CDH Investments, TusStar Incubator — 17 tracked in total.
- Status: Privately Held (backing).
Who backs CSR Biotech
17+- ·The complete investor list: 17 names
- ·Watch CSR Biotech: the Monday email on marks, rounds and moves
CSR Biotech funding rounds
No funding rounds for CSR Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CSR Biotech investors
17 investors are on record for CSR Biotech, including CAS Star, Qiming Venture Partners, Fortune Capital and CDH Investments.
About CSR Biotech
Developer and manufacturer of super-resolution imaging instruments for living cells. The company focuses on the research, development and application of super-resolution imaging instruments for living cells and provides services including customized cell sample production service, customized cell sample high-throughput detection service, customized cell sample imaging experiment service, customized image post-processing and quantitative analysis service, and customized high-dimensional spatio-temporal data visualization service, enabling bio researchers with tool to discover new disease biomarkers and innovative drug targets.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2019
- Employees
- 80
- Website
- csr-biotech.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CSR Biotech doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.